Oral Nystatin Prophylaxis to Prevent Systemic Fungal Infection in Very Low Birth Weight Preterm Infants
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study determines the effectiveness of oral nystatin as prophylaxis in order to prevent
systemic fungal infection in very low birth weight preterm neonates. 47 participants received
oral nystatin and 48 participants received sterile water as part of oral hygiene.